However, these drugs and derivatives have also demonstrated potential pharmacological activity and can act, for instance, against cancer [52], allergy [53], bacterial [54], fungal infections [55], and also as targeting agents for the cholecystokinin 2 receptor (CCK2R), which is overexpressed in some people [56,57]. Here, CCKBR is linked to fungal infectious disease.